Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Amyotrophic Lateral Sclerosis Treatment Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 Sanofi S.A.
5.1.1 Sanofi S.A. Company Profile
5.1.2 Sanofi S.A. Business Overview
5.1.3 Sanofi S.A. Amyotrophic Lateral Sclerosis Treatment Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Sanofi S.A. Amyotrophic Lateral Sclerosis Treatment Products Introduction
5.2 Mitsubishi Tanabe Pharma
5.2.1 Mitsubishi Tanabe Pharma Company Profile
5.2.2 Mitsubishi Tanabe Pharma Business Overview
5.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Products Introduction
5.3 Mylan Pharmaceuticals Inc.
5.3.1 Mylan Pharmaceuticals Inc. Company Profile
5.3.2 Mylan Pharmaceuticals Inc. Business Overview
5.3.3 Mylan Pharmaceuticals Inc. Amyotrophic Lateral Sclerosis Treatment Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Mylan Pharmaceuticals Inc. Amyotrophic Lateral Sclerosis Treatment Products Introduction
5.4 Takeda Pharmaceutical Company Ltd.
5.4.1 Takeda Pharmaceutical Company Ltd. Company Profile
5.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
5.4.3 Takeda Pharmaceutical Company Ltd. Amyotrophic Lateral Sclerosis Treatment Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Takeda Pharmaceutical Company Ltd. Amyotrophic Lateral Sclerosis Treatment Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Amyotrophic Lateral Sclerosis Treatment Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Amyotrophic Lateral Sclerosis Treatment Sales and Market Share by Types (2015-2020)
6.1.2 Global Amyotrophic Lateral Sclerosis Treatment Revenue and Market Share by Types (2015-2020)
6.1.3 Global Amyotrophic Lateral Sclerosis Treatment Price by Types (2015-2020)
6.2 Global Amyotrophic Lateral Sclerosis Treatment Market Forecast by Types (2020-2025)
6.2.1 Global Amyotrophic Lateral Sclerosis Treatment Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Amyotrophic Lateral Sclerosis Treatment Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Amyotrophic Lateral Sclerosis Treatment Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Amyotrophic Lateral Sclerosis Treatment Sales, Price and Growth Rate of Riluzole
6.3.2 Global Amyotrophic Lateral Sclerosis Treatment Sales, Price and Growth Rate of Edaravone (Radicava)
6.4 Global Amyotrophic Lateral Sclerosis Treatment Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Riluzole Market Revenue and Sales Forecast (2020-2025)
6.4.2 Edaravone (Radicava) Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Amyotrophic Lateral Sclerosis Treatment Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Amyotrophic Lateral Sclerosis Treatment Sales and Market Share by Applications (2015-2020)
7.1.2 Global Amyotrophic Lateral Sclerosis Treatment Revenue and Market Share by Applications (2015-2020)
7.2 Global Amyotrophic Lateral Sclerosis Treatment Market Forecast by Applications (2020-2025)
7.2.1 Global Amyotrophic Lateral Sclerosis Treatment Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Amyotrophic Lateral Sclerosis Treatment Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Amyotrophic Lateral Sclerosis Treatment Revenue, Sales and Growth Rate of Hospital Pharmacies (2015-2020)
7.3.2 Global Amyotrophic Lateral Sclerosis Treatment Revenue, Sales and Growth Rate of Retail & Online Pharmacies (2015-2020)
7.4 Global Amyotrophic Lateral Sclerosis Treatment Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Hospital Pharmacies Market Revenue and Sales Forecast (2020-2025)
7.4.2 Retail & Online Pharmacies Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Amyotrophic Lateral Sclerosis Treatment Sales by Regions (2015-2020)
8.2 Global Amyotrophic Lateral Sclerosis Treatment Market Revenue by Regions (2015-2020)
8.3 Global Amyotrophic Lateral Sclerosis Treatment Market Forecast by Regions (2020-2025)

9 North America Amyotrophic Lateral Sclerosis Treatment Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Amyotrophic Lateral Sclerosis Treatment Market Sales and Growth Rate (2015-2020)
9.3 North America Amyotrophic Lateral Sclerosis Treatment Market Revenue and Growth Rate (2015-2020)
9.4 North America Amyotrophic Lateral Sclerosis Treatment Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Amyotrophic Lateral Sclerosis Treatment Market Analysis by Country
9.6.1 U.S. Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
9.6.2 Canada Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
9.6.3 Mexico Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate

10 Europe Amyotrophic Lateral Sclerosis Treatment Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Amyotrophic Lateral Sclerosis Treatment Market Sales and Growth Rate (2015-2020)
10.3 Europe Amyotrophic Lateral Sclerosis Treatment Market Revenue and Growth Rate (2015-2020)
10.4 Europe Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Amyotrophic Lateral Sclerosis Treatment Market Analysis by Country
10.6.1 Germany Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
10.6.2 United Kingdom Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
10.6.3 France Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
10.6.4 Italy Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
10.6.5 Spain Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
10.6.6 Russia Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate

11 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Analysis by Country
11.6.1 China Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
11.6.2 Japan Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
11.6.3 South Korea Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
11.6.4 Australia Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
11.6.5 India Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate

12 South America Amyotrophic Lateral Sclerosis Treatment Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Amyotrophic Lateral Sclerosis Treatment Market Sales and Growth Rate (2015-2020)
12.3 South America Amyotrophic Lateral Sclerosis Treatment Market Revenue and Growth Rate (2015-2020)
12.4 South America Amyotrophic Lateral Sclerosis Treatment Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Amyotrophic Lateral Sclerosis Treatment Market Analysis by Country
12.6.1 Brazil Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
12.6.2 Argentina Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
12.6.3 Columbia Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate

13 Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Market Analysis by Country
13.6.1 UAE Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
13.6.2 Egypt Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate
13.6.3 South Africa Amyotrophic Lateral Sclerosis Treatment Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source